Harrer, A.
2233  results:
Search for persons X
?
2

P06.19.A BEYOND T CELL TOXICITY - INTRATHECAL CXCL13 ELEVAT..:

Bieler, L ; Otto, F ; Seiberl, M...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii50-ii50 , 2023
 
?
5

Komplexe Deformitätenkorrektur:

Harrer, J. ; Schröter, S.
Knie Journal.  4 (2022)  1 - p. 2-3 , 2022
 
?
6

Immune phenotyping study revealing caveats regarding a swit..:

Radlberger, RF ; Sakic, I ; Moser, T...
Multiple Sclerosis and Related Disorders.  48 (2021)  - p. 102727 , 2021
 
?
 
?
8

Epitope competition and neutralizing antidrug antibodies: i..:

Harrer, A. ; Lang, R. ; Kölblinger, P.
British Journal of Dermatology.  183 (2020)  2 - p. 404-404 , 2020
 
?
9

On absolute linear Harbourne constants:

Dumnicki, M. ; Harrer, D. ; Szpond, J.
Finite Fields and Their Applications.  51 (2018)  - p. 371-387 , 2018
 
?
 
?
 
?
12

High interindividual variability in the CD4/CD8 T cell rati..:

Harrer, A ; Pilz, G ; Wipfler, P...
Clinical and Experimental Immunology.  180 (2015)  3 - p. 383-392 , 2015
 
?
13

High-dose intravenous interferon-beta in multiple sclerosis..:

Hegen, H. ; Guger, M. ; Harrer, A....
Multiple Sclerosis and Related Disorders.  3 (2014)  2 - p. 220-226 , 2014
 
?
14

Tumefactive MS lesions under fingolimod: A case report and ..:

Pilz, G. ; Harrer, A. ; Wipfler, P....
Journal of the Neurological Sciences.  333 (2013)  - p. e400 , 2013
 
?
15

Flow-cytometry and the detection of anti-natalizumab NAB in..:

Oppermann, K. ; Harrer, A. ; Pilz, G....
Journal of the Neurological Sciences.  333 (2013)  - p. e389-e390 , 2013
 
1-15